DCVC
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Quantum Motion
7 May 2026
Quantum Motion announces its £120m Series C led by DCVC and Kembara to build silicon quantum computers using standard chip manufacturing
Quantum Motion builds quantum computers using silicon transistors manufactured with the same technology as conventional computer chips. Its systems are designed to reduce cost, space and energy use while fitting into standard data centre infrastructure.
Alchemab Therapeutics
9 Sept 2025
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Alchemab identifies naturally occurring protective antibodies using AI and patient data, developing new therapies based on disease resilience rather than traditional target discovery.
DCVC
- 2(12 months)
- dcvc.com
- Update Information
More venture news
- 7 May 2026
Quantum MotionQuantum Motion announces its £120m Series C led by DCVC and Kembara to build silicon quantum computers using standard chip manufacturing
Series CDeep Tech - 7 May 2026
NyoboltNyobolt raises £44m in funding led by Symbotic to build ultra-fast charging batteries for autonomous machines and data centres
Series CEnergy - 23 Apr 2026
CloudsmithCloudsmith announces £53m Series C led by TCV to control and secure the software supply chain
Series CDeveloper Tools
